AlphaGenome: DeepMind's Unified DNA Sequence Model for Regulatory Variant-Effect Prediction
DeepMind has introduced AlphaGenome, a new unified DNA sequence model designed to advance regulatory variant-effect prediction and improve understanding of genome function. The model is now available via API, making it accessible to researchers. AlphaGenome represents a significant step in applying large-scale AI to genomics, particularly for interpreting non-coding regulatory regions of the genome.
Related guides (3)
Related events (8)
Google's AlphaGenome Interprets Non-Coding DNA That Regulates Genetic Expression
Google has released AlphaGenome, an open-weights model that interprets the ~98% of human and mouse genomes that regulate gene expression rather than coding for proteins. The model takes up to 1 million DNA base pairs as input and outputs roughly 6,000 human and 1,000 mouse gene properties, using a CNN-transformer-CNN architecture trained via ensemble distillation from 64 pretrained models. Across 50 evaluations, AlphaGenome matched or exceeded prior models in 47 cases, and correctly predicted expression changes associated with T-cell acute lymphoblastic leukemia. Weights, API, and inference code are freely available for noncommercial use.
AlphaEvolve: A Gemini-powered coding agent for designing advanced algorithms
DeepMind has announced AlphaEvolve, a coding agent powered by Gemini that autonomously evolves algorithms for mathematical and practical computing applications. The system combines large language model creativity with automated evaluators to iteratively improve algorithmic solutions. It represents a significant step in AI-driven algorithm discovery, extending DeepMind's prior work in this space (e.g., AlphaTensor, FunSearch). The announcement comes from DeepMind's official blog, indicating a substantive capability release rather than a research preview.
AlphaEvolve: How our Gemini-powered coding agent is scaling impact across fields
DeepMind published a blog post detailing the real-world impact of AlphaEvolve, a Gemini-powered coding agent designed to discover and optimize algorithms. The post covers applications spanning business operations, infrastructure, and scientific research. AlphaEvolve represents a deployment of LLM-driven evolutionary algorithm search at scale across multiple domains.
DeepMind Launches 27B Parameter Gemma-Based Foundation Model for Single-Cell Analysis
DeepMind has released a new 27 billion parameter foundation model built on the Gemma open-model family, specifically designed for single-cell biological analysis. The model contributed to the discovery of a new potential cancer therapy pathway. This represents a significant application of large language model architecture to computational biology and genomics research.
AlphaFold: Five Years of Impact
DeepMind published a retrospective on AlphaFold's five-year impact on biological research and scientific discovery. The post surveys how the protein structure prediction system has accelerated science globally since its initial release. As a tier-1 source anniversary piece, it likely highlights cumulative usage statistics, downstream research enabled, and future directions.
AlphaFold Reveals Structure of Key Heart Disease Protein
DeepMind has used AlphaFold to determine the structure of a key protein implicated in heart disease. The announcement highlights a new scientific application of AlphaFold's protein structure prediction capabilities to cardiovascular research. This represents a continued expansion of AlphaFold's impact on biomedical discovery beyond its initial structural biology applications.
Finding the molecular switches behind new infectious diseases
DeepMind's Co-Scientist AI tool is being used by researcher Clare Bryant to identify genetic triggers in emerging infectious diseases. The application demonstrates Co-Scientist's utility in accelerating biological discovery, specifically in understanding molecular mechanisms underlying new pathogens. This represents a concrete scientific use case for AI-assisted research in infectious disease biology.
Decoding genetics with OpenAI o1
Geneticist Catherine Brownstein demonstrates OpenAI o1's application to rare disease diagnosis, showing how the model can accelerate the interpretation of complex genetic data. The post highlights o1's reasoning capabilities in a specialized scientific domain. This represents a capability demonstration for o1 in high-stakes medical genetics use cases.